Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$25.9M |
| 2 |
Automatic Data Processing
ADP
|
+$7.91M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$7.59M |
| 4 |
HES
Hess
HES
|
+$7.13M |
| 5 |
NLSN
Nielsen Holdings plc
NLSN
|
+$7.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$8.9M |
| 2 |
TransDigm Group
TDG
|
+$8.9M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$7.17M |
| 4 |
Howmet Aerospace
HWM
|
+$6.82M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$6.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.35% |
| 2 | Consumer Discretionary | 14.2% |
| 3 | Industrials | 13.49% |
| 4 | Healthcare | 12.93% |
| 5 | Consumer Staples | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Air Products & Chemicals
APD
$67.9B
| $463K | 0.02% |
+1,611
| New | +$473K |
|
702
Rambus
RMBS
$9.9B
| $463K | 0.02% |
19,546
-9,905
| -34% | -$199K |
|
703
Group 1 Automotive
GPI
$3.12B
| $460K | 0.02% |
2,978
-3,539
| -54% | -$568K |
|
704
Pacira BioSciences
PCRX
$983M
| $460K | 0.02% |
7,582
+301
| +4% | +$19.1K |
|
705
Lincoln National
LNC
$8.07B
| $459K | 0.02% |
7,310
+1,620
| +28% | +$107K |
|
706
Marriott Vacations Worldwide
VAC
$3.87B
| $458K | 0.02% |
2,875
-849
| -23% | -$145K |
|
707
Petrobras
PBR
$123B
| $457K | 0.02% |
37,350
+185
| +0.5% | +$1.82K |
|
708
Helen of Troy
HELE
$677M
| $454K | 0.02% |
1,988
-2,188
| -52% | -$481K |
|
|
TBIO
709
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $454K | 0.02% |
16,467
+7
| +0% | +$138 |
|
|
WCC
710
WESCO International
WCC
$17B
| $453K | 0.02% |
4,404
+139
| +3% | +$13.8K |
|
711
Zscaler
ZS
$29.4B
| $451K | 0.02% |
+2,089
| New | +$397K |
|
|
FOE
712
DELISTED
Ferro Corporation
FOE
| $450K | 0.02% |
+20,868
| New | +$410K |
|
|
SC
713
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $449K | 0.02% |
12,363
+2,562
| +26% | +$89K |
|
|
EFOR
714
Everforth Inc
EFOR
$1.34B
| $448K | 0.02% |
4,624
+2,397
| +108% | +$245K |
|
715
FTI Consulting
FCN
$4.3B
| $448K | 0.02% |
3,280
-1,895
| -37% | -$267K |
|
716
Dana Inc
DAN
$3.41B
| $447K | 0.02% |
18,829
-2,019
| -10% | -$52.3K |
|
|
LGF.B
717
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $445K | 0.02% |
24,326
-2,052
| -8% | -$31.4K |
|
718
OSI Systems
OSIS
$3.41B
| $444K | 0.02% |
4,364
+764
| +21% | +$74.4K |
|
719
Apogee Enterprises
APOG
$868M
| $443K | 0.02% |
10,868
-4,190
| -28% | -$158K |
|
720
Gray Television
GTN
$509M
| $443K | 0.02% |
18,926
-14,905
| -44% | -$323K |
|
|
MASI
721
DELISTED
Masimo
MASI
| $442K | 0.02% |
1,825
+12
| +0.7% | +$2.74K |
|
|
COOP
722
DELISTED
Mr. Cooper
COOP
| $438K | 0.02% |
13,234
+120
| +0.9% | +$4.01K |
|
723
Cavco Industries
CVCO
$4.48B
| $437K | 0.02% |
1,968
-315
| -14% | -$68.6K |
|
724
Workiva
WK
$4.07B
| $435K | 0.02% |
3,907
-1,700
| -30% | -$165K |
|
|
HOUS
725
DELISTED
Anywhere Real Estate
HOUS
| $434K | 0.02% |
23,846
+10,089
| +73% | +$172K |
|
Similar funds
Joel Greenblatt's Q2 2021 Portfolio in Review
As of Q2 2021, Joel Greenblatt held 1,160 positions worth $2.36B, up 5.3% from $2.24B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Joel Greenblatt's Q2 2021 filing shows 181 new, 351 increased, 440 reduced and 178 closed positions. Its largest new stake was Vertex Pharmaceuticals: 36,305 shares worth $7.32M. The largest sale was eBay, an estimated $8.9M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Joel Greenblatt's largest Q2 2021 buy was Vertex Pharmaceuticals: 36,305 shares worth $7.32M.
- Joel Greenblatt added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $25.9M increase.
- Joel Greenblatt's biggest Q2 2021 reduction was eBay, cutting an estimated $8.9M.
- Joel Greenblatt fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $6.35M.
- Joel Greenblatt's ten largest holdings make up 13% of its $2.36B portfolio in Q2 2021.
- Joel Greenblatt opened 181 new positions and closed 178 in Q2 2021.
- Joel Greenblatt's portfolio value rose 5.3% quarter-over-quarter to $2.36B.
Based on Gotham Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.